GERN Overview
Upcoming Projects (GERN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GERN)
-
Exploring Imetelstat's Role in Treating Transfusion-Dependent Anemia in Lower-Risk MDS: A Deep Dive into Geron's Clinical Advancements
Ticker: GERN
Executed On: Apr 01, 2024 at 02:30 PM EDT -
Quarterly Survey: LR-MDS Pts RBC Transfusions and Reblozyl (luspatercept) - October 2023
Tickers: BMY, MRK, GERN, ELRN
Executed On: Nov 02, 2023 at 05:25 PM EDT -
Quarterly Survey: LR-MDS Pts RBC Transfusions and Reblozyl (luspatercept) - July 2023
Tickers: BMY, MRK, GERN, ELRN
Executed On: Aug 01, 2023 at 03:55 PM EDT -
A Second Opinion: Discussing Bristol Myers' COMMANDS (Reblozyl) & Geron's iMERGE (imetelstat) data from ASCO 2023 in MDS
Tickers: BMY, GERN
Executed On: Jun 26, 2023 at 01:00 PM EDT -
Discussing Bristol Myers' COMMANDS (Reblozyl) & Geron's iMERGE (imetelstat) data from ASCO 2023 in MDS
Tickers: BMY, GERN
Executed On: Jun 07, 2023 at 02:00 PM EDT -
Quarterly Survey: BMY's Reblozyl (luspatercept) and LR-MDS requiring Red Blood Cell Transfusions May 2023
Tickers: BMY, XLRN, MRK, GERN
Executed On: May 10, 2023 at 12:29 PM EDT -
Discussing Geron’s Imetelstat Treatment in Lower Risk MDS Patients
Ticker: GERN
Executed On: Feb 21, 2023 at 12:00 PM EST
Upcoming & Overdue Catalysts (GERN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (GERN)
